Trials / Sponsors / Gritstone bio, Inc.
Gritstone bio, Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Pa Colonic Neoplasms, Colorectal Neoplasms | Phase 2 | 2022-05-19 |
| Completed | Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and P COVID-19, SARS-CoV-2 | Phase 1 | 2022-02-28 |
| Completed | A Screening Study Targeting Tumor-specific Antigens Metastatic Colorectal Cancer, Stage II/III Colon Cancer | — | 2021-12-14 |
| Completed | Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers COVID-19 | Phase 1 | 2021-09-16 |
| Completed | A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | 2019-07-18 |
| Completed | A Study of a Personalized Neoantigen Cancer Vaccine Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma | Phase 1 / Phase 2 | 2019-02-13 |
| Completed | A Study of Personalized Neoantigen Cancer Vaccines Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma | — | 2018-07-25 |